Property Detail Full Name Body Protection Compound 157 Amino Acids 15 (pentadecapeptide) Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Molecular Weight ~1,419 g/mol Forms reviewed by FDA Free base and acetate salt FDA Status Not approved Active IND applications None (as of April 2026) Compounding status Under reclassification review (July 23-24, 2026) Is BPC-157 FDA Approved in 2026
The selection criterion is injury pattern: single-site, localized damage responds best to BPC-157
Based on the local contexts of Tainan City, an appropriate evaluation framework for PEDs will be developed
doi: 10.1016/j.ajog.2020.11.005 12
Este medicamento es producido y exportado por AdvaCare Pharma
Dosage-unit testing Finally, For capsules or tablets, evaluate content uniformity, assay, weight variation, disintegration, and other suitable finished-product tests